Sven Wehrwein, Director at AtriCure, Inc. (ATRC), sold 25,000 shares at $37.84 ($946K) on 2026-07-28, disclosed to the SEC on 2026-07-30.
Open-market sale of $946k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2025-08-26 | $185K | — | Filing → |
| ATRC | SELL | 2025-08-21 | $180K | — | Filing → |
| SPSC | SELL | 2024-08-13 | $725K | — | Filing → |